Additionally, within treatment groups, IC-delivered ProtheraCytes had significantly more VEGFr1 expression than in ProtheraCytes-treated stroke animals via IA (*P < .05) and IN (****P < .0001). This evidence concerns the gene FLT1 and Stroke.